Vivos Therapeutics (VVOS) Depreciation & Amortization (IS) (2020 - 2025)
Historic Depreciation & Amortization (IS) for Vivos Therapeutics (VVOS) over the last 6 years, with Q3 2025 value amounting to $384000.0.
- Vivos Therapeutics' Depreciation & Amortization (IS) rose 16301.37% to $384000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 7252.56%. This contributed to the annual value of $581000.0 for FY2024, which is 644.12% down from last year.
- According to the latest figures from Q3 2025, Vivos Therapeutics' Depreciation & Amortization (IS) is $384000.0, which was up 16301.37% from $306000.0 recorded in Q2 2025.
- Vivos Therapeutics' Depreciation & Amortization (IS)'s 5-year high stood at $384000.0 during Q3 2025, with a 5-year trough of $144000.0 in Q4 2024.
- Its 5-year average for Depreciation & Amortization (IS) is $186684.2, with a median of $175000.0 in 2022.
- As far as peak fluctuations go, Vivos Therapeutics' Depreciation & Amortization (IS) crashed by 2600.0% in 2023, and later soared by 16301.37% in 2025.
- Vivos Therapeutics' Depreciation & Amortization (IS) (Quarter) stood at $168000.0 in 2021, then rose by 0.6% to $169000.0 in 2022, then fell by 11.83% to $149000.0 in 2023, then dropped by 3.36% to $144000.0 in 2024, then skyrocketed by 166.67% to $384000.0 in 2025.
- Its last three reported values are $384000.0 in Q3 2025, $306000.0 for Q2 2025, and $177000.0 during Q1 2025.